Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
PH 结构域富含亮氨酸的蛋白磷酸酶 (Phlpp)1 在破骨细胞中的功能
基本信息
- 批准号:10237904
- 负责人:
- 金额:$ 30.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-21 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAddressAffectAgeAgingAllelesAmericanAnimalsArthritisAttenuatedBindingBiochemicalBiological AssayBone DensityBone DiseasesBone ResorptionBone remodelingCSF1R geneCell NucleusCellsChemicalsControl AnimalCytoplasmDataDeveloped CountriesDiseaseEconomic BurdenEnterobacteria phage P1 Cre recombinaseEpigenetic ProcessEstrogen ReplacementsEstrogen TherapyEstrogensEventExhibitsFractureFrightGenetic TranscriptionGoalsHealthcare SystemsHip FracturesHistonesHospitalizationHumanIn VitroIndividualKnock-outKnockout MiceKnowledgeLeucineLoxP-flanked alleleMacrophage Colony-Stimulating FactorMaintenanceMeasuresModelingMolecularMorbidity - disease rateMusNuclearOperative Surgical ProceduresOsteoclastsOsteogenesisOsteopeniaOsteoporosisOvariectomyPH DomainPathway interactionsPeriodontitisPhenotypePhosphorylationPopulationProcessProtein phosphatasePublishingQuality of lifeReceptor Protein-Tyrosine KinasesRoleSerious Adverse EventTestingTranslatingUnited StatesWild Type MouseWomanWorkbasebonebone massconditional knockoutcortical bonefracture riskhigh riskin vivoinnovationmenmicroCTmortalitymutantnovelosteoclast progenitorosteoclastogenesisosteoporosis with pathological fracturepromoterprotective effectpublic health relevancereconstitutionresponsesocialstem cellssubstantia spongiosatumor
项目摘要
Abstract
Osteoporosis is a significant cause of morbidity and mortality in developed countries. In the United States, over
8 million women and 2 million men age 50 and above have osteoporosis. Another 51 million women and 35
million men have osteopenia. This translates into a higher risk of fracture within this population, with half of all
women and one quarter of men projected to suffer a low bone mass-related fracture. Osteoporotic fractures
impart deleterious consequences, including increased hospitalization and mortality. An estimated 25% of
individuals will die within one year of a hip fracture. Despite the availability of anti-resorptive therapies that
decrease fracture rates, their prescription and use have declined significantly due to fears of extremely rare but
serious adverse events. This has created a treatment gap that threatens the quality of life of millions of
Americans and poses a tremendous challenge to our healthcare systems and economy. It also highlights the
need to better understand osteoclast formation and function. The goal of this five-year application is to
determine the role of the protein phosphatase Phlpp1 in osteoclastogenesis and bone density and to define the
epigenetic mechanisms required for Phlpp1 to modulate Csf1r (c-fms) expression and osteoclastogenesis. The
five-year deliverables are: 1) definition of the functions of Phlpp1 in osteoclast progenitor cells, 2)
characterization of the cytosolic functions of Phlpp1 that influence M-CSF responsiveness, Csfr1 expression
and osteoclast function, and 3) determination of the nuclear functions of Phlpp1 that influence Csfr1
transcription and osteoclastogenesis. This work will increase our understanding of how Phlpp1 and associated
pathways affect bone density.
摘要
骨质疏松症是发达国家发病率和死亡率的重要原因。在美国,结束了
800万50岁及以上的女性和200万男性患有骨质疏松症。另有5100万名女性和35名
有数百万男性患有骨质疏松症。这转化为该人群中更高的骨折风险,有一半的人
女性和四分之一的男性预计会遭受与低骨量相关的骨折。骨质疏松性骨折
造成有害后果,包括增加住院和死亡率。估计有25%的人
个人将在髋部骨折后一年内死亡。尽管有抗吸收疗法可用,
降低骨折发生率,他们的处方和使用已经显著下降,因为担心极其罕见但
严重的不良事件。这造成了一个治疗缺口,威胁到数百万人的生活质量
并对我们的医疗体系和经济构成了巨大的挑战。它还突出了
需要更好地了解破骨细胞的形成和功能。这项为期五年的申请的目标是
确定蛋白磷酸酶PHLPP1在破骨细胞形成和骨密度中的作用,并确定
PHLPP1调节CSF1R(c-FMS)表达和破骨细胞生成所需的表观遗传学机制。这个
五年的交付成果是:1)PHLPP1在破骨细胞前体细胞中的功能定义,2)
影响M-CSF反应性和Csfr1表达的PHLPP1的胞浆功能特征
和破骨细胞功能,以及3)影响Csfr1的PHLPP1核功能的测定
转录和破骨细胞发生。这项工作将增加我们对PHLPP1和关联的理解
途径会影响骨密度。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Serine/threonine phosphatases in osteoclastogenesis and bone resorption.
- DOI:10.1016/j.gene.2020.145362
- 发表时间:2021-03-01
- 期刊:
- 影响因子:3.5
- 作者:Karkache IY;Damodaran JR;Molstad DHH;Bradley EW
- 通讯作者:Bradley EW
Myeloid Lineage Ablation of Phlpp1 Regulates M-CSF Signaling and Tempers Bone Resorption in Female Mice.
- DOI:10.3390/ijms22189702
- 发表时间:2021-09-08
- 期刊:
- 影响因子:5.6
- 作者:Karkache IY;Damodaran JR;Molstad DHH;Mansky KC;Bradley EW
- 通讯作者:Bradley EW
Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.
- DOI:10.1371/journal.pone.0251732
- 发表时间:2021
- 期刊:
- 影响因子:3.7
- 作者:Hanson MK;Karkache IY;Molstad DHH;Norton AA;Mansky KC;Bradley EW
- 通讯作者:Bradley EW
Phlpp1 Expression in Osteoblasts Plays a Modest Role in Bone Homeostasis.
- DOI:10.1002/jbm4.10806
- 发表时间:2023-12
- 期刊:
- 影响因子:3.8
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth W Bradley其他文献
Elizabeth W Bradley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth W Bradley', 18)}}的其他基金
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
PH 结构域富含亮氨酸的蛋白磷酸酶 (Phlpp)1 在破骨细胞中的功能
- 批准号:
10001986 - 财政年份:2017
- 资助金额:
$ 30.91万 - 项目类别:
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
PH 结构域富含亮氨酸的蛋白磷酸酶 (Phlpp)1 在破骨细胞中的功能
- 批准号:
9761459 - 财政年份:2017
- 资助金额:
$ 30.91万 - 项目类别:
Epigenetic Regulation of Phlpp1 in Cartilage Development and Regeneration
Phlpp1 在软骨发育和再生中的表观遗传调控
- 批准号:
8893005 - 财政年份:2014
- 资助金额:
$ 30.91万 - 项目类别:
Runx2 and Axin2 Interactions During Bone Formation
Runx2 和 Axin2 在骨形成过程中的相互作用
- 批准号:
8334718 - 财政年份:2011
- 资助金额:
$ 30.91万 - 项目类别:
Runx2 and Axin2 Interactions During Bone Formation
Runx2 和 Axin2 在骨形成过程中的相互作用
- 批准号:
8195738 - 财政年份:2011
- 资助金额:
$ 30.91万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 30.91万 - 项目类别:
Research Grant